DNA-PK inhibitors
Compounds of formula I: wherein A, B and D are respectively selected from the group consisting of: (i) CH, NH, C; (ii) CH, N, N; and (iii) CH, O, C; the dotted lines represent two double bonds in the appropriate locations; and where Z is selected from S, O, C( O), CH2 and NH are disclosed for use in...
Saved in:
Main Authors | , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
19.10.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Compounds of formula I: wherein A, B and D are respectively selected from the group consisting of: (i) CH, NH, C; (ii) CH, N, N; and (iii) CH, O, C; the dotted lines represent two double bonds in the appropriate locations; and where Z is selected from S, O, C( O), CH2 and NH are disclosed for use in inhibiting DNA-PK. |
---|---|
AbstractList | Compounds of formula I: wherein A, B and D are respectively selected from the group consisting of: (i) CH, NH, C; (ii) CH, N, N; and (iii) CH, O, C; the dotted lines represent two double bonds in the appropriate locations; and where Z is selected from S, O, C( O), CH2 and NH are disclosed for use in inhibiting DNA-PK. |
Author | XIAO-LING FAN COCKCROFT KEITH ALLAN MENEAR MARINE DESAGE-EL MURR KAPPUSAMY SARAVANAN NIALL MORRISON BARR MARTIN IAN ROBERT HARDCASTLE BERNARD THOMAS GOLDING HILARY ALAN CALVERT MARK FRIGERIO NICOLA JANE CURTIN DAVID RICHARD NEWELL MARC GEOFFREY HUMMERSONE ROGER JOHN GRIFFIN GRAEME CAMERON MURRAY SMITH |
Author_xml | – fullname: NIALL MORRISON BARR MARTIN – fullname: DAVID RICHARD NEWELL – fullname: MARK FRIGERIO – fullname: KAPPUSAMY SARAVANAN – fullname: BERNARD THOMAS GOLDING – fullname: HILARY ALAN CALVERT – fullname: XIAO-LING FAN COCKCROFT – fullname: GRAEME CAMERON MURRAY SMITH – fullname: NICOLA JANE CURTIN – fullname: MARINE DESAGE-EL MURR – fullname: ROGER JOHN GRIFFIN – fullname: MARC GEOFFREY HUMMERSONE – fullname: KEITH ALLAN MENEAR – fullname: IAN ROBERT HARDCASTLE |
BookMark | eNrjYmDJy89L5WQQdPFz1A3wVsjMy8hMyizJLyrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgZmRsam5saGjobGxKkCAMoZIXY |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2006235731A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2006235731A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:20:54 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2006235731A13 |
Notes | Application Number: AU20060235731 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061019&DB=EPODOC&CC=AU&NR=2006235731A1 |
ParticipantIDs | epo_espacenet_AU2006235731A1 |
PublicationCentury | 2000 |
PublicationDate | 20061019 |
PublicationDateYYYYMMDD | 2006-10-19 |
PublicationDate_xml | – month: 10 year: 2006 text: 20061019 day: 19 |
PublicationDecade | 2000 |
PublicationYear | 2006 |
RelatedCompanies | CANCER RESEARCH TECHNOLOGY LIMITED KUDOS PHARMACEUTICALS LIMITED |
RelatedCompanies_xml | – name: CANCER RESEARCH TECHNOLOGY LIMITED – name: KUDOS PHARMACEUTICALS LIMITED |
Score | 2.6616688 |
Snippet | Compounds of formula I: wherein A, B and D are respectively selected from the group consisting of: (i) CH, NH, C; (ii) CH, N, N; and (iii) CH, O, C; the dotted... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | DNA-PK inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061019&DB=EPODOC&locale=&CC=AU&NR=2006235731A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU80MU8zNQLvdTLRNTFLMdZNMk0y0E0zNUuyNDFONjBKBg0N-PqZeYSaeEWYRjAx5MD2woDPCS0HH44IzFHJwPxeAi6vCxCDWC7gtZXF-kmZQKF8e7cQWxc1eO8YmMIs1VycbF0D_F38ndWcnYE9STW_ILAc6GQXY0NHYF-JFdSQBp207xrmBNqXUoBcqbgJMrAFAM3LKxFiYErNE2bgdIbdvSbMwOELnfIGMqG5r1iEQdDFz1E3wFshMy8jMykTdE2OKIOym2uIs4cu0Ox4uFfiHUORHWIsxsAC7OSnSjAoJFkCQ9PcHNh5SEwxSbI0TTIzMTUwSTI2SjJNNjc2T5FkkMFnkhR-aWkGLvDQAWglhqUMA0tJUWmqLLAyLUmSA4cBAF1ndLA |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOfbnIofUwdK34p1SRr6MKTrB9WtXZFO9laWtsOC1OEq_vtewjb3tLeQwJEcuRy_y93vAB74nPIF66taJ6pTMye6YMLQF8wUFiWZ0c9kaCCMzGBKX2ds1oDPTS2M4gn9VeSIaFEZ2nut3uvlfxDLVbmVq0dR4tTXs58MXG2LjvGGWZo7HHjxxJ04muMgktSiN7UmmV3Ik41Y6YAjKJRM-977UNalLHedit-GwxjlVfUJNIqqAy1n03utA0fh-ssbh2vrW51C241sPR71yuqjFKVsk3MG976XOIGOstPtUVJ7ursRcg5NBPnFBfSEhdrkHMHDPKfCYsKkzKCC9AXLOOH5JXT3Sbrav3wHrSAJx-n4JRpdw7EKI8isDKsLzfr7p7hBx1qLW6WPP_fBd5s |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DNA-PK+inhibitors&rft.inventor=NIALL+MORRISON+BARR+MARTIN&rft.inventor=DAVID+RICHARD+NEWELL&rft.inventor=MARK+FRIGERIO&rft.inventor=KAPPUSAMY+SARAVANAN&rft.inventor=BERNARD+THOMAS+GOLDING&rft.inventor=HILARY+ALAN+CALVERT&rft.inventor=XIAO-LING+FAN+COCKCROFT&rft.inventor=GRAEME+CAMERON+MURRAY+SMITH&rft.inventor=NICOLA+JANE+CURTIN&rft.inventor=MARINE+DESAGE-EL+MURR&rft.inventor=ROGER+JOHN+GRIFFIN&rft.inventor=MARC+GEOFFREY+HUMMERSONE&rft.inventor=KEITH+ALLAN+MENEAR&rft.inventor=IAN+ROBERT+HARDCASTLE&rft.date=2006-10-19&rft.externalDBID=A1&rft.externalDocID=AU2006235731A1 |